The insulin-like growth factor I receptor: a key to tumor growth? - PubMed (original) (raw)
. 1995 Jan 15;55(2):249-52.
Affiliations
- PMID: 7812953
The insulin-like growth factor I receptor: a key to tumor growth?
R Baserga. Cancer Res. 1995.
Abstract
The insulin-like growth factor I receptor (IGF-IR) belongs to the family of transmembrane tyrosine kinase receptors, like the receptors for platelet-derived growth factor, the epidermal growth factor, insulin, and others. Genetic evidence has shown that the IGF-IR is required for optimal growth in vitro and in vivo. Even more important, however, have been recent findings from several laboratories clearly showing that the IGF-IR is an absolute requirement for the establishment and maintenance of the transformed phenotype, both in vivo and in vitro and in several cell types. These findings indicate that the IGF-IR plays a central role in the mechanism of transformation and, as such, could be a preferred target for therapeutic interventions.
Similar articles
- Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
Rubin R, Baserga R. Rubin R, et al. Lab Invest. 1995 Sep;73(3):311-31. Lab Invest. 1995. PMID: 7564264 Review. - The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.
Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R. Resnicoff M, et al. Cancer Res. 1995 Jun 1;55(11):2463-9. Cancer Res. 1995. PMID: 7758000 - Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K, Hongo A, Kodama J, Miyagi Y, Yoshinouchi M, Kudo T. Nakamura K, et al. Cancer Res. 2000 Feb 1;60(3):760-5. Cancer Res. 2000. PMID: 10676665 - Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice.
Furlanetto RW, Harwell SE, Baggs RB. Furlanetto RW, et al. Cancer Res. 1993 Jun 1;53(11):2522-6. Cancer Res. 1993. PMID: 8495414 - Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H, Nilsson K. Jernberg-Wiklund H, et al. Adv Cancer Res. 2007;97:139-65. doi: 10.1016/S0065-230X(06)97006-7. Adv Cancer Res. 2007. PMID: 17419944 Review.
Cited by
- EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
Prieur A, Tirode F, Cohen P, Delattre O. Prieur A, et al. Mol Cell Biol. 2004 Aug;24(16):7275-83. doi: 10.1128/MCB.24.16.7275-7283.2004. Mol Cell Biol. 2004. PMID: 15282325 Free PMC article. - Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.
Werner H, Karnieli E, Rauscher FJ, LeRoith D. Werner H, et al. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8318-23. doi: 10.1073/pnas.93.16.8318. Proc Natl Acad Sci U S A. 1996. PMID: 8710868 Free PMC article. - Aberrant signaling pathways in glioma.
Nakada M, Kita D, Watanabe T, Hayashi Y, Teng L, Pyko IV, Hamada J. Nakada M, et al. Cancers (Basel). 2011 Aug 10;3(3):3242-78. doi: 10.3390/cancers3033242. Cancers (Basel). 2011. PMID: 24212955 Free PMC article. - Nuclear insulin-like growth factor-1 receptor (IGF1R) displays proliferative and regulatory activities in non-malignant cells.
Solomon-Zemler R, Sarfstein R, Werner H. Solomon-Zemler R, et al. PLoS One. 2017 Sep 25;12(9):e0185164. doi: 10.1371/journal.pone.0185164. eCollection 2017. PLoS One. 2017. PMID: 28945762 Free PMC article. - Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.
Zhang YC, Wang XP, Zhang LY, Song AL, Kou ZM, Li XS. Zhang YC, et al. World J Gastroenterol. 2006 Jul 7;12(25):3977-82. doi: 10.3748/wjg.v12.i25.3977. World J Gastroenterol. 2006. PMID: 16810743 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases